Glycobiology of Lung Inflammatory Diseases (Programs of Excellence in Glycosciences)
Funded by: The National Heart, Lung, and Blood Institute (NHLBI); Grant #: P01HL107151

Shared Resources Core - Carbohydrate Synthesis
Specific Aims:
• Produce large scale quantities of advanced intermediates required for the production of targeted sialoside ligands.
• Produce sialoside ligands of siglecs to support projects of the Lung Inflammatory Disease (LID-PEG) program.

Compounds also available to the scientific community for nominal charge to cover costs associated with producing the compounds and shipping.

For more information, please contact the Core Director, Dr. Corwin Nycholat (email: nycholat@scripps.edu).



Sialoside ligands intermediates in stock (green) or available upon request ( yellow)
Glycan No.	Structure	Azide	Amine	Biotinylated	PAA (1 MDa)	(PEG)-Lipid	Lipid
1		1 mg	1 mg	50 ug	50 ug	1mg	1mg
2		1 mg	1 mg	50 ug	50 ug	1mg	1mg
3		NA	1 mg	50 ug	50 ug	1mg	1mg
4		NA	1 mg	50 ug	50 ug	1mg	1mg
5		1 mg	1 mg	50 ug	50 ug	1mg	1mg
6		1 mg	1 mg	50 ug	50 ug	1mg	1mg

Paulson Laboratory      Created by: Anna